Government ❯Regulation ❯FDA ❯Vaccine Approval

Public Health Policy

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval

Regulators will review Moderna’s standalone flu vaccine application later this year based on Phase 3 results showing superior efficacy

FDA Expands Approval of GSK's RSV Vaccine to Adults Aged 50-59